Design, synthesis, and antimelanogenic effects of (2-substituted phenyl-1,3-dithiolan-4-yl)methanol derivatives. 2017

Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
College of Pharmacy, Pusan National University, Busan.

The authors designed and synthesized 17 (2-substituted phenyl-1,3-dithiolan-4-yl) methanol (PDTM) derivatives to find a new chemical scaffold, showing excellent tyrosinase-inhibitory activity. Their tyrosinase-inhibitory activities were evaluated against mushroom tyrosinase at 50 μM, and five of the PDTM derivatives (PDTM3, PDTM7-PDTM9, and PDTM13) were found to inhibit mushroom tyrosinase more than kojic acid or arbutin, the positive controls. Of seventeen PDTMs, PDTM3 (half-maximal inhibitory concentration 13.94±1.76 μM), with a 2,4-dihydroxyphenyl moiety, exhibited greatest inhibitory effects (kojic acid half-maximal inhibitory concentration 18.86±2.14 μM). Interestingly, PDTM compounds with no hydroxyl group, PDTM7-PDTM9, also had stronger inhibitory activities than kojic acid. In silico studies of interactions between tyrosinase and the five PDTMs suggested their binding affinities were closely related to their tyrosinase-inhibitory activities. Cell-based experiments performed using B16F10 mouse-skin melanoma cells showed that PDTM3 effectively inhibited melanogenesis and cellular tyrosinase activity. A cell-viability study conducted using B16F10 cells indicated that the antimelanogenic effect of PDTM3 was not attributable to its cytotoxicity. Kinetic studies showed PDTM3 competitively inhibited tyrosinase, indicating binding to the tyrosinase-active site. We found that PDTM3 with a new chemical scaffold could be a promising candidate for skin-whitening agents, and that the 1,3-dithiolane ring could be used as a chemical scaffold for potent tyrosinase inhibition.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000363 Agaricales An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms. Agaricaceae,Mushrooms,Agaricale,Mushroom
D000432 Methanol A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness. Alcohol, Methyl,Carbinol,Sodium Methoxide,Wood Alcohol,Alcohol, Wood,Methoxide, Sodium,Methyl Alcohol
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
January 2009, Acta poloniae pharmaceutica,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
January 2015, Bioorganic & medicinal chemistry letters,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
January 2009, Indian journal of pharmaceutical sciences,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
June 2012, Acta crystallographica. Section E, Structure reports online,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
March 2023, Pharmaceuticals (Basel, Switzerland),
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
April 2012, Chemical biology & drug design,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
May 2012, Bioorganic & medicinal chemistry letters,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
October 2012, Acta crystallographica. Section E, Structure reports online,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
December 2012, Acta crystallographica. Section E, Structure reports online,
Do Hyun Kim, and Su Jeong Kim, and Sultan Ullah, and Hwi Young Yun, and Pusoon Chun, and Hyung Ryong Moon
July 2011, ChemMedChem,
Copied contents to your clipboard!